Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Opal

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 1992
Emergence and nosocomial transmission of ampicillin-resistant enterococciJ M Boyce, S M Opal, G Potter-Bynoe, et al.
The Journal of Infectious Diseases|November 9, 2000
Chemotactic activity of CXC chemokines interleukin-8, growth-related oncogene-alpha, and epithelial cell-derived neutrophil-activating protein-78 in urine of patients with urosepsisD P Olszyna, S M Opal, J M Prins, et al.
Annals of Internal Medicine|July 15, 1994
Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprintingD L Horn, D Hewlett, W H Haas, et al.
The Journal of Experimental Medicine|March 1, 1995
Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoidsJ S Orange, T P Salazar-Mather, S M Opal, et al.
Kidney International|June 15, 2001
Release of urokinase plasminogen activator receptor during urosepsis and endotoxemiaS Florquin, J G van den Berg, D P Olszyna, et al.
The Journal of Infectious Diseases|March 18, 2000
Differential antibiotic-induced endotoxin release in severe melioidosisA J Simpson, S M Opal, B J Angus, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulationJ Kienast, M Juers, C J Wiedermann, et al.
The Journal of Clinical Investigation|September 1, 1991
Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsisS M Opal, A S Cross, J C Sadoff, et al.
The New England Journal of Medicine|June 27, 1996
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study GroupC J Fisher, J M Agosti, S M Opal, et al.
Critical Care Medicine|January 1, 1994
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trialC J Fisher, G J Slotman, S M Opal, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|May 1, 1992
Emergence and nosocomial transmission of ampicillin-resistant enterococciJ M Boyce, S M Opal, G Potter-Bynoe, et al.
The Journal of Infectious Diseases|November 9, 2000
Chemotactic activity of CXC chemokines interleukin-8, growth-related oncogene-alpha, and epithelial cell-derived neutrophil-activating protein-78 in urine of patients with urosepsisD P Olszyna, S M Opal, J M Prins, et al.
Annals of Internal Medicine|July 15, 1994
Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprintingD L Horn, D Hewlett, W H Haas, et al.
The Journal of Experimental Medicine|March 1, 1995
Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoidsJ S Orange, T P Salazar-Mather, S M Opal, et al.
Kidney International|June 15, 2001
Release of urokinase plasminogen activator receptor during urosepsis and endotoxemiaS Florquin, J G van den Berg, D P Olszyna, et al.
The Journal of Infectious Diseases|March 18, 2000
Differential antibiotic-induced endotoxin release in severe melioidosisA J Simpson, S M Opal, B J Angus, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulationJ Kienast, M Juers, C J Wiedermann, et al.
The Journal of Clinical Investigation|September 1, 1991
Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsisS M Opal, A S Cross, J C Sadoff, et al.
The New England Journal of Medicine|June 27, 1996
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study GroupC J Fisher, J M Agosti, S M Opal, et al.
Critical Care Medicine|January 1, 1994
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trialC J Fisher, G J Slotman, S M Opal, et al.
Pageof 11